Canopus Bioscience:
A Vital Link to Cancer Theranostics
With this high value test:
  • Oncologists are able to identify patients who won't respond to a drug or
  • who will respond poorly, reducing trial-and-error prescription and adverse
    events, thereby delivering more cost-effective care.
  • Patients are guaranteed of better outcomes and safer treatments
  • Pharmaceutical companies lower the cost and time of drug
  • development, clinical trials and regulatory approval, by pinpointing those
    patients most likely to benefit from the new drug being tested.
    Canopus Bioscience
    Copyright All Rights Reserved